Consumers report negligible savings despite price caps in Republika Srpska

Although the decision to limit margins on several essential food items in the Republika Srpska entity has been in effect for nearly a month, consumers report that these products have yet to become any more affordable.
Oglas
The RS Ministry of Trade and Tourism has thus far declined to comment on the impact of the measure, which is scheduled to remain in place until 1 June. However, consumer protection advocates suggest they are entirely unsurprised by the lack of downward movement in shelf prices.
"We were not involved in the drafting of the decision on limited margins, but our stance has been clear for some time. Margins ought to be capped on entire product categories rather than individual items. For instance, the limit should have applied to all bakery goods, not merely wheat bread," stated Jovan Vasilic, President of the "Zvono" consumer protection association in Bijeljina.
Vasilic noted that his organisation has been inundated with enquiries from across the RS, with citizens asking if any genuine agreements had been reached with retailers. "Why was there no cap on meat and meat products? These are not luxuries; they are basic staples," he added.
Official data from the RS Statistics Agency is expected within a week, though the full statistical impact of the measures will likely not be evidenced until May. Annual food price inflation in the RS was recorded at 3.3% in February.
The RS Government initially introduced the margin caps on ten essential consumer items and specific medicines on 21 March. The Minister of Trade and Tourism, Ned Puhovac, stated the objective was to stabilise the rising cost of basic foodstuffs. Under the current rules, the maximum wholesale margin is set at 6% with retail capped at 8%. For medicines not covered by the Health Insurance Fund, margins are restricted to 8% wholesale and 20% retail.
While Minister Puhovac expressed an expectation that prices would fall, he was unable to provide a specific forecast for the magnitude of these reductions. Patients purchasing prescription medication via the Health Insurance Fund will see no change in costs, as the new limits apply exclusively to non-subsidised drugs.
Kakvo je tvoje mišljenje o ovome?
Učestvuj u diskusiji ili pročitaj komentare
Oglas
Kakvo je tvoje mišljenje o ovome?
Učestvuj u diskusiji ili pročitaj komentare
Oglas
NAJČITANIJE
Oglas
Oglas
Najnovije
Oglas
Oglas